Profil
Lars Ole Öhman is currently the Chairman at Lipigon Pharmaceuticals AB, Betulaceae Pharmaceuticals AB, Kubera Pharmaceuticals AB, and Director at Kubator Therapeutics AB, Cordator Life Science AB, and Immunscape AB. He previously worked as the Vice President-Business Development at Karo Healthcare AB. Mr. Öhman has an MBA from Stockholm School of Economics and an undergraduate degree from the Royal Institute of Technology.
Postes actifs de Lars Ole Öhman
| Sociétés | Poste | Début |
|---|---|---|
| LIPIGON PHARMACEUTICALS AB | Président | 01/01/2012 |
Kubator Therapeutics AB | Directeur/Membre du Conseil | 01/07/2012 |
Kubera Pharmaceuticals AB | Président | 01/07/2012 |
Betulaceae Pharmaceuticals AB | Président | - |
Cordator Life Science AB | Directeur/Membre du Conseil | 01/01/2018 |
Immunscape AB | Directeur/Membre du Conseil | 01/07/2016 |
Anciens postes connus de Lars Ole Öhman
| Sociétés | Poste | Fin |
|---|---|---|
| KARO PHARMA AB (PUBL) | Corporate Officer/Principal | - |
Formation de Lars Ole Öhman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Karo Healthcare AB
Karo Healthcare AB Household/Personal CareConsumer Non-Durables Manufactures skincare products, cosmetics, supplements and digestive pharmaceuticals | Consumer Non-Durables |
Stockholm School of Economics
Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royal Institute of Technology
Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lipigon Pharmaceuticals AB
Lipigon Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops drugs aiming at treating dyslipidemia patients | Health Technology |
Kubator Therapeutics AB | |
Betulaceae Pharmaceuticals AB | |
Kubera Pharmaceuticals AB | |
Cordator Life Science AB | |
Immunscape AB |
















